Obesity, metabolic syndrome, and primary hypertension.
Litwin M, Kułaga Z.
Pediatr Nephrol. 2021 Apr;36(4):825-837. doi: 10.1007/s00467-020-04579-3. Epub 2020 May 9.
Childhood Primary Hypertension: Not Uncommon, Not Benign.
Halbach SM, Flynn JT.
Hypertension. 2023 Jun;80(6):1197-1198. doi: 10.1161/HYPERTENSIONAHA.123.21041. Epub 2023 May 17.
Systolic hypertension in children: benign or beware?
Sorof JM.
Pediatr Nephrol. 2001 Jun;16(6):517-25. doi: 10.1007/s004670100586.
Patients with uncontrolled hypertension or concomitant hypertension and benign prostatic hyperplasia.
Zusman R.
Clin Cardiol. 2004 Feb;27(2):63-9. doi: 10.1002/clc.4960270203.
White Coat Hypertension: A Benign Finding or a Masked Risk Factor?
Kavian JA.
South Med J. 2023 Dec;116(12):962-963. doi: 10.14423/SMJ.0000000000001628.
Treatment of benign prostatic hyperplasia and hypertension in elderly hypertensive patients.
Suzuki H.
Br J Urol. 1998 Mar;81 Suppl 1:51-5. doi: 10.1046/j.1464-410x.1998.0810s1051.x.
Proteinuria and hypertension.
Ritz E, Nowicki M, Fliser D, Hörner D, Klimm HP.
Kidney Int Suppl. 1994 Nov;47:S76-80.
The epidemiology of benign prostatic hyperplasia and observations on concomitant hypertension.
Boyle P, Napalkov P.
Scand J Urol Nephrol Suppl. 1995;168:7-12.
Cost-effective monotherapy of concomitant benign prostatic hyperplasia and hypertension.
Altwein JE.
Br J Hosp Med. 1997 Dec 10;58(11):592-4.
[Benign hypertension].
KALLNER S.
Sven Lakartidn. 1962 Sep 6;59:2492.
